Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin, (Digoxin) - Assessing the Potential Higher Risk of Death Compared to Patients not Using Digoxin

Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared to patients not using digoxin. Results of the studies suggested that digoxin use may be linked with a higher risk of death when compared to patients not using digoxin, especially among patients diagnosed with an irregular heart rhythm.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Résumé de l'examen de l'innocuité – Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin (digoxine) – Évaluation du potentiel de risque de décès accru chez les patients traités à la digoxine comparativement aux patients non traités à la digoxine
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Summary Safety Review", "Lanoxin", "Toloxin", "Apo-digoxin", "PMS-digoxin", "Digoxin", "assessing", "potential higher risk", "risk of Death"], "en": ["Summary Safety Review", "Lanoxin", "Toloxin", "Apo-digoxin", "PMS-digoxin", "Digoxin", "assessing", "potential higher risk", "risk of Death"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source